- The study examined how effective and safe nifedipine GITS and ramipril are for treating hypertension in Chinese versus European patients through a post-hoc analysis of a multinational trial.
- The research found that while both medications reduced blood pressure similarly across ethnic groups, ethnic differences impacted age, body mass index, and certain blood pressure measurements, and the response to treatment varied between the two groups.
- The safety profiles noted significant differences, with fewer adverse events in Chinese patients taking nifedipine, while Europeans experienced more ankle edema with nifedipine and dry cough with ramipril.
Patients with hypertension who engage with mobile health technologies show lower blood pressure and better understanding of their condition.
This study evaluated the reliability and validity of the TWEETS scale specifically for Italian patients with hypertension for the first time.
Results indicated that TWEETS is effective and reliable for measuring patient engagement with mHealth devices, but more research is needed across different populations to confirm its applicability.
Twenty-four-hour ambulatory blood pressure monitoring (ABPM) is now widely recognized as a key tool for diagnosing hypertension, moving from specialist-only use to broader applications.
Advances in technology and the growing emphasis on hypertension diagnosis have allowed general practitioners and trained non-medical providers, like in community pharmacies, to utilize ABPM effectively.
To mitigate confusion around roles and responsibilities in the use of ABPM, experts from the Italian Society of Hypertension created a guide for training healthcare professionals in its proper implementation and management.
* It compared two groups of patients with treated hypertension: one group monitored during the pandemic and another monitored before it, looking at changes in hypertension phenotypes like sustained uncontrolled hypertension (SUCH) and sustained controlled hypertension (SCH).
* Results showed no significant changes in the pandemic group’s hypertension phenotypes, while the pre-pandemic group saw an increase in SCH and a decrease in SUCH, suggesting the pandemic negatively impacted blood pressure management.